Press Releases and Bulletins


For more information on these press releases, contact: 

J. Benjamin Younger Office of Public Affairs
409 12th Street SW, Suite 602
Washington, DC 20024-2188
Tel: (202) 863-2494/Fax: (202) 484-4039 

  • What Women Want: Survey Shows Women’s Patterns and Desires About Contraception

    <span class="TextRun SCXW254141772 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW254141772 BCX0">Philadelphia, PA</span></span><span class="TextRun SCXW254141772 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW254141772 BCX0">&nbsp;&ndash; Research presented at the 75</span></span><span class="TextRun SCXW254141772 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun Superscript SCXW254141772 BCX0" data-fontsize="11">th</span></span><span class="TextRun SCXW254141772 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW254141772 BCX0">&nbsp;Scientific Congress and Expo of the American Society for Reproductive Medicine reveals interesting patterns about how women use contraception now, and what their preferences might be moving forward.</span></span><span class="EOP SCXW254141772 BCX0" data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span>
  • A New Hormonal Treatment for Ectopic Pregnancy: Letrozole Is as Effective as Methotrexate

    <span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">Philadelphia, PA</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">&mdash;Today, at the American Society for&nbsp;</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">Reproductive</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">&nbsp;</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">M</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">edicine&rsquo;s 77</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun Superscript SCXW29011292 BCX0" data-fontsize="12">th</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">&nbsp;Scientific Congress and Expo, US and</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">&nbsp;Egyptian researchers presented a prospective cohort study&nbsp;</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">showing for the first time&nbsp;</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">that&nbsp;</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">l</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">etrozole, an aromatase inhibitor,&nbsp;</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">is as</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">&nbsp;effective as methotrexate</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">&nbsp;</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">as a medical treatment to end&nbsp;</span></span><span class="TextRun SCXW29011292 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW29011292 BCX0">ectopic pregnancy.</span></span><span class="EOP SCXW29011292 BCX0" data-ccp-props="{}">&nbsp;</span>
  • Expanded Carrier Screening for Genetic Diseases in an Ashkenazi Jewish Population

    <span class="TextRun SCXW256413333 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW256413333 BCX0">Philadelphia, PA</span></span><span class="TextRun SCXW256413333 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW256413333 BCX0">&nbsp;-&nbsp;</span></span><span class="TextRun SCXW256413333 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW256413333 BCX0">Offering prospective parents of Ashkenazi Jewish background an expanded panel of carrier screening for genetic disorders could help decrease even further the transmission of certain autosomal recessive conditions</span></span><span class="TextRun SCXW256413333 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW256413333 BCX0">&nbsp;to children.</span></span><span class="EOP SCXW256413333 BCX0" data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}">&nbsp;</span>
  • Irregular or Extra Long Periods May Portend a Shorter Life Span

    <p><em>Philadelphia, PA</em>- Abnormal menstrual cycle characteristics- irregularity and extra-long cycle length- are associated with greater risk of mortality according to a study presented at the American Society for Reproductive Medicine&rsquo;s 75<sup>th</sup> Scientific Congress and Expo.&nbsp; In a prospective cohort study, researchers from Harvard and Tongji Medical College in China teamed up to analyze data on 93,775 women, followed for the years 1991 to 2013 as part of the Nurses Health Study II.</p>
  • Children of Gestational Carriers Express Positive Feelings about the Experience, Pride in their Mothers’ Efforts to Help Others

    <p><em>Philadelphia, PA</em>&mdash;Today, at the 75<sup>th</sup> Scientific Congress and Expo of the American Society for Reproductive Medicine, researchers presented a study of families of gestational carriers (GCs) in which they found that the majority of GCs&rsquo; children surveyed reported positive emotions about the surrogacy experience.</p>
  • Early Life Exposures Impact the Odds of an Endometriosis Diagnosis

    <p><em>Philadelphia, PA</em>--&nbsp; New results from The Women&rsquo;s Health Study: From Adolescence to Adulthood (A2A)&nbsp; presented at ASRM&rsquo;s 75<sup>th</sup> annual Scientific Congress and Expo reveal that in addition to having a hereditary component, the odds a young woman will be diagnosed with endometriosis are influenced by early life exposures, like whether or not she was &nbsp;breastfed or if her parents smoked during pregnancy or around their children.</p>
  • ASRM Announces New President

    <h3><em>Philadelphia, PA- </em>ASRM is excited to announce our new President, Catherine Racowsky Ph.D., HCLD. Dr. Racowsky is currently the Director of the ART Laboratory at Brigham &amp; Women&rsquo;s Hospital in Boston, Massachusetts and Professor of Obstetrics and Gynecology at Harvard Medical School. She served as ASRM&rsquo;s secretary for eleven years before transitioning to Vice President.</h3>
  • ASRM Announces New Board Members and Affiliated Society Presidents

    <p>ASRM is delighted to announce the new affiliated society presidents and new directors joining the Board.</p>
  • African American Women with Cancer Less Likely to Utilize Fertility Preserving Egg Freezing

    <p><em><span data-contrast="auto">Philadelphia, PA</span></em><span data-contrast="auto"> &ndash; Researchers from New York University presented research today at the 75</span><span data-contrast="auto">th</span><span data-contrast="auto"> Scientific Congress of the American Society for Reproductive Medicine showing that African-American and Hispanic women with cancer were less likely to utilize fertility preserving treatments than white women.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}">&nbsp;</span></p>
  • Egg Donors Report Good Long-Term Physical Health Status and Satisfaction with their Experience

    <p><em><span data-contrast="auto">Philadelphia, PA</span></em><span data-contrast="auto">- </span><span data-contrast="auto">Researchers shared results today, at the 75</span><span data-contrast="auto">th</span><span data-contrast="auto"> Annual Scientific Congress of the American Society for Reproductive Medicine, that m</span><span data-contrast="auto">ost egg donors</span><span data-contrast="auto"> surveyed&nbsp;</span> <span data-contrast="auto">report</span><span data-contrast="auto">ed </span><span data-contrast="auto">positive feelings about their donation experience and </span><span data-contrast="auto">continuing good health</span><span data-contrast="auto"> years after their donation.&nbsp; Dr. Jennifer Blackmore and her colleagues analyzed responses to </span><span data-contrast="auto">an anonymous survey </span><span data-contrast="auto">completed by 36 </span><span data-contrast="auto">egg donors who donated between 2008 and 2019 at New York University&rsquo;s Langone Fertility Center.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}">&nbsp;</span></p>
  • Men, Seriously. What Are You Thinking?

    Philadelphia, PA- A preliminary analysis of results from an online survey show that men in the United States know somewhat less about fertility and infertility treatment than women do and are particularly optimistic- or confused- when it comes to what they think they know about female fertility and age.
  • Maternal Pre-Diabetes Is Associated with Sex Chromosome Abnormalities in IVF Embryos

    <p><em><span data-contrast="auto">Philadelphia, PA-</span></em> <span data-contrast="auto">Embryos from pre-diabetic patients are more </span><span data-contrast="auto">than twice as </span><span data-contrast="auto">likely to have sex chromosome aneuploidies than embryos from patients with normal levels of glycated hemoglobin.</span><span data-ccp-props="{}">&nbsp;</span></p>
  • State Infertility Insurance Mandates Leave out Many

    <p><em><span data-contrast="auto">Philadelphia, Pa</span></em><span data-contrast="auto"> &ndash; Research presented at the 75</span><span data-contrast="auto">th</span><span data-contrast="auto"> Scientific Congress of the American Society for Reproductive Medicine today showed that many patients are still not covered for their infertility despite the passage of infertility insurance mandates by the states.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}">&nbsp;</span></p>
  • Revised Guidelines Expanding Single Embryo Transfer Guidelines Result in Fewer Multiple Births at the Clinic Level and the National Level, Without a Decline in Live Birth Rates

    <p style="text-align: left;"><em><span data-contrast="auto">Philadelphia, PA</span></em><em><span data-contrast="auto">-</span></em> <span data-contrast="auto">Today, at the 75</span><span data-contrast="auto">th</span><span data-contrast="auto"> Annual Scientific Congress an</span><span data-contrast="auto">d</span><span data-contrast="auto"> Expo of the American Society for Reproductive Medicine, researcher</span><span data-contrast="auto">s from the National Institute o</span><span data-contrast="auto">f Child Health and Human Development and Walter Reed </span><span data-contrast="auto">National Military Medical Center presented results from a </span><span data-contrast="auto">retrospective cohort study in </span><span data-contrast="auto">which they compared Assisted Reproductive Technology outcomes</span><span data-contrast="auto"> in women under 38 years of age</span><span data-contrast="auto"> from </span><span data-contrast="auto">the two years before and the two years </span><span data-contrast="auto">after the 2017 revision of the ASRM/SART embryo transfer recommendations</span><span data-contrast="auto">. The</span><span data-contrast="auto"> data showed a significant reduction in th</span><span data-contrast="auto">e number of embryos transferred and in </span><span data-contrast="auto">twin pregnancy rates</span><span data-contrast="auto">,</span><span data-contrast="auto"> but no reduction in over all live birth rate</span><span data-contrast="auto">s after the </span><span data-contrast="auto">new recommendations were published and implemented.</span><span data-ccp-props="{}">&nbsp;</span></p>
  • ASRM Research Institute Receives First Seven Figure Gift. Dr. Thomas S. Kosasa of Honolulu Gives $1 Million to Fund New research effort

    <p>&nbsp;</p> <p><em>Washington, DC</em>&ndash; The ASRM Research Institute, a new research arm of the American Society for Reproductive Medicine, announced today that Thomas S. Kosala MD of Honolulu, HI, a Life Member of the ASRM, was making a million-dollar gift to the new institute.</p>
  • Marijuana Use by Fathers Poses Risk for Miscarriage

    <p><em>Philadelphia, PA</em> &ndash; Research presented today at the 75<sup>th</sup> Scientific Congress of the American Society for Reproductive Medicine revealed that there is an association between marijuana use of the father and miscarriage.&nbsp;</p>
  • The Higher the Motile Sperm Count, the Greater the Number of Historical Kinfolk; Sperm Quality Measure May Be Heritable

    Philadelphia, PA- Utah researchers presented a study today at ASRM&rsquo;s 75th Scientific Congress and Expo showing that there is a relationship between a man&rsquo;s total motile sperm count (TMC) as a marker of fertility, and the number of offspring his ancestors had through several generations. The better an individual&rsquo;s TMC, the more children his ancestors had.
  • Racial Disparities in Fertility Care Persist

    <p><em>Philadelphia, PA</em> &ndash; Research presented today at the 75<sup>th</sup> Scientific Congress of the American Society for Reproductive Medicine showed that while there had been a slight uptick in the use of Assisted Reproductive Technologies (ART) among African American women over the last decade, significant disparities remain.</p>
  • Jury May Still Be out on Caffeine Use During Pregnancy

    <p><em>Philadelphia, PA </em>&ndash; The ongoing debate about the safety of caffeine use during pregnancy got another data point today at the 75<sup>th</sup> Scientific Congress of the American Society for Reproductive Medicine. A team at the National Institutes of Health presented a study showing that the use of any level of caffeine, particularly during the first eight weeks of pregnancy, may increase the risk of pregnancy loss.</p>
  • Preimplantation Genetic Testing for Chromosomal Defects Improves IVF Outcomes in Patients with Recurrent Pregnancy Loss

    <p><em>Philadelphia, PA- </em>In the largest study to date examining the usefulness of preimplantation genetic testing for aneuploidy (PGT-A), for patients with recurrent pregnancy loss (RPL), Rutgers researchers report that PGT-A is associated with significant improvements in live birth, clinical pregnancy, and spontaneous abortion rates, especially in women over the age of 35.</p>
  • ICSI Smoothie? Cocktail of Beetroot, Watermelon and Ginger Juice Show Promise in Helping Infertility Treatments

    Philadelphia, PA &ndash; A study of nearly 300 infertility patients undergoing Intracytoplasmic Sperm Injection (ICSI) were enrolled in a clinical study to evaluate the effectiveness of certain nutritional supplements. The investigators found that the patients receiving the supplements had increased embryo implantation rates, higher clinical pregnancy rates and lower miscarriage rates than those in the control group.
  • Medical Society to Move Headquarters Out of Alabama

    <p><em>Washington, DC</em> &ndash; The American Society for Reproductive Medicine, a major medical association celebrating its 75<sup>th</sup> anniversary this year, announced today it was moving its main headquarters from Birmingham, AL to Washington DC. The move comes in reaction to new laws in Alabama restricting access to reproductive medical services.</p>
  • ASRM 75th Anniversary Gala SOLD OUT

    <p>The ASRM 75th Anniversary Gala to be held in Philadelphia on October 13th is completely sold out.</p> <p>We look forward to this very special event. If you were unable to get a ticket for this year&rsquo;s gala, stay tuned for information on a similar event at the ASRM 2020 Scientific Congress &amp; Expo in Portland.</p>
  • ASRM Announces Research Awards

    <p><em>Washington DC</em> &ndash; The American Society for Reproductive Medicine today announced its 2019 ASRM Research Grants. The grants provide funds in amounts of $10,000 to $50,000 to foster the development of innovative research, to facilitate the research endeavors of new investigators, and to provide bridge funding for projects that advance the Society&rsquo;s mission. Proposals from junior faculty, particularly those in their first three years of faculty appointment, received priority in the competitive review by the ASRM Research Committee.&nbsp;</p> <p>&nbsp;</p>
  • New Hampshire Expands Fertility Coverage to Employer-Sponsored Health Plans

    <p>On August 1<sup>st</sup>, Republican Governor Chris Sununu of New Hampshire signed SB 279 into law. This bill, passed by the legislature in late June, will expand insurance coverage for fertility care by requiring employer-sponsored plans to cover the care as well as the storage of sperm, eggs and embryos for the length of the policy. Group plans will also be required to cover fertility preservation for patients who must undergoe medically necessary treatment that may cause iatrogenic infertility. The new law will take effect on January 1, 2020.</p>
  • House Passes National Defense Authorization Act with Language Addressing Infertility in Servicewomen; Rep. Scott Introduces Fibroid Awareness Resolution

    <p>On July 12<sup>th</sup>, the House passed the&nbsp;National Defense Authorization Act&nbsp;(NDAA) for 2020 by a vote of 220-197. The House version of the NDAA&nbsp;includes language calling for a Study on Infertility Among Members of the Armed Forces no later than 180 days after enactment. The findings will then be reported back to the members of the House Committee on Armed Services. The study will assess the number of members of the Armed Forces serving as of&nbsp;the date of the study who are diagnosed with common causes of&nbsp;infertility, such as:&nbsp;</p>
  • ASRM names Dr. Ricardo Azziz as new CEO

    <p>The American Society for Reproductive Medicine (ASRM) today announced the appointment of Ricardo Azziz, MD, MPH, MBA to serve as the Society&rsquo;s Chief Executive Officer beginning in January 2020.</p>
  • ASRM Joins Briefs Challenging Administration’s Title X Regulations and Calls on Congress to Support the Program

    <p>Today, ASRM joined with 30 other healthcare organizations, to file amicus briefs in three states, Washington, Oregon and California, all within the jurisdiction of the Ninth Circuit Court, in cases against HHS Secretary Alex Azar.</p>
  • ASRM One of Ten National Health Organizations Urging Supreme Court to Find Louisiana Law Unconstitutional

    Today, ASRM joined with nine other healthcare organization, led by ACOG, to file an amicus brief with the US Supreme Court in the case June Medical Services LLC v. Rebekah Gee.<br /><br />In September 2018, the Fifth Circuit Court of Appeals overruled a challenge to a Louisiana law requiring that physicians providing abortion care have admitting privileges at a hospital within 30 miles of their clinics. The Louisiana law they upheld is virtually identical to the Texas law found unconstitutional by the Supreme Court in Whole Women&rsquo;s Health vs. Texas in 2016.
  • Access to Infertility Treatment and Care Act Introduced

    <p><em>Washington, DC</em>-- The Access to Infertility Treatment and Care Act (HR 2803 and S 1461) just introduced in Congress will require all health plans offered on the group and individual markets to provide coverage for the treatment of infertility. The Federal Employees Health Benefits Program, TRICARE, the VA and Medicaid are also included under the Act. In addition, the Act will require coverage for fertility preservation services for individuals who undergo a medically necessary procedure that may cause infertility, such as chemotherapy.</p>
  • Advocacy Day 2019: ASRM Went to Capitol Hill to Garner Support for New Legislation to Ensure All Americans Have Coverage for Fertility Care

    <p>This year&rsquo;s turnout was the largest to date, with 233 patients and professionals- members of ASRM and RESOLVE from 29 states and the District of Columbia-&nbsp; in Washington, DC yesterday to meet with their Senators and Representatives to let them know how they can help Americans build their families via support for legislation important to the infertility community.&nbsp; Before heading out to the Hill, advocates heard first hand from Rep. Debbie Wasserman Schultz, a long-time champion of legislation to help the infertility community, about her personal infertility and cancer journeys, and her call to action.</p>
  • ASRM CEO, Richard Reindollar, Send Letter Urging Alabama Governor Kay Ivey To Veto Abortion Criminalization Bill

    I am writing on behalf of the American Society for Reproductive Medicine (ASRM) to urge you to veto HB 314 which criminalizes physicians&rsquo; efforts to provide needed medical care to their patients.
  • ASRM Ethics Committee Updates Two Opinions

    <p>The Ethics Committee of the American Society for Reproductive Medicine has updated two of its opinions: &ldquo;Fertility treatment when the prognosis is very poor or futile&rdquo; and &ldquo;Interests, obligations, and rights in gamete and embryo donation.&rdquo;</p>
  • Oral Contraceptives May Limit Bone Loss in Young Anorexic Patients

    <p>French researchers have identified a promising protective effect of oral contraceptives on the bone health of young women with anorexia nervosa.&nbsp; Along with the gynecological disorders resulting from anorexia, patients experience bone loss with intense demineralization early in the course of the disease. This study shows for the first time that anorexia patients using oral contraceptives (OCs) have a higher areal bone mineral density than those who do not use OCs&nbsp; and suggests that, while regularly taking an oral contraceptive will not confer complete protection, it may help to limit bone loss in young women suffering from anorexia nervosa.</p>
  • ASRM and RESOLVE Announce New Partnership Agreement

    <p>ASRM is proud to announce that we have entered into an agreement with RESOLVE: the National Infertility Association to form a new partnership focused on access to care and patient education efforts. ASRM and RESOLVE have a long and successful history of working together to improve conditions for patients, and this agreement brings a new, more formal status to that relationship. The joint efforts will focus on three areas: supporting RESOLVE&rsquo;s <u>Coverage at Work </u>initiative, working together on policy advocacy efforts, and improving ASRM&rsquo;s Patient Education offerings.</p> <p>&nbsp;</p>
  • Latest Data from SART Show Increasing Use of Cryopreservation for Fertility Preservation

    <p>The Society for Assisted Reproductive Technology, the United States&rsquo; primary organization of professionals dedicated to the practice of assisted reproductive technologies (ART) is releasing its latest national and clinic-specific ART data, today.</p>
  • American Society for Reproductive Medicine “Ecstatic and Grateful” for Passage of Updated Infertility Requirement in New York Budget Measure

    <p><em>Washington, DC</em> -&nbsp;The American Society for Reproductive Medicine (ASRM) applauds the news that New York has passed a long overdue update to the state&rsquo;s infertility statute as part of its budget bill today.</p>
  • New York Becomes Tenth State to Require Coverage of IVF and Sixth State to Require Coverage for Fertility Preservation for Certain Patients

    <p>New York lawmakers passed a budget measure late yesterday which updates the state&rsquo;s existing infertility statute to include a requirement for health plans operating in the large group market (employers with 100 or more full-time staff) to provide coverage for three cycles of in-vitro fertilization. The budget measure also includes a provision requiring that patients at risk for iatrogenic infertility be covered for fertility preservation services.&nbsp;</p>
  • DEADLINE April 26, 2019 - The ASRM Research Institute Solicits its First Round of Major Grant Applications

    <p>The newly established ASRM Research Institute invites applications from investigators to develop research projects addressing fundamental questions of major clinical significance to reproductive medicine. Preference for funding will be given to projects that attempt to answer timely, basic and clinically relevant questions of potential high impact to the practice of reproductive medicine and which are currently not fundable (either because of applicable existing federal law or because of relatively lower prioritization) by federal funding agencies. Applicants are advised to review the recently published ASRM Research Blueprint identifying the list of research priorities for the Society.</p>
  • ASRM Goes to Geneva for the World Health Organization’s Global Summit on Safety and Access to Fertility Care

    <p>This week, members of ASRM&rsquo;s leadership team are meeting with other leaders in reproductive health from around the world in Geneva, Switzerland. The WHO is holding its Global Summit on Safety and Access to Fertility Care to develop strategies for improving access to safe, ethical, and cost-effective fertility care, particularly in developing countries. This conference follows up on an ASRM-sponsored meeting in 2015.</p>
  • ASRM Statement on Reports of Human Reproductive Gene-Editing in China

    <p>Statement attributable to ASRM President, Peter Schlegel, MD.</p> <p>&nbsp;</p> <p>&ldquo;We have reviewed the report of He Jiankui of Shanghai, China, regarding the initiation of a twin pregnancy after premature human application of the unfolding scientific technique of CRISPER/Cas to modify genes in human embryos as part of an in vitro fertilization (IVF) procedure.&nbsp; Although gene editing may have an important place in human medicine in the future, it should only be used clinically after careful study done with vigorous oversight.&nbsp;</p>
  • ASRM Announces New Chief Medical Officer William Hurd MD, Takes on Revised Position

    <p>Birmingham, AL &ndash; The American Society for Reproductive Medicine (ASRM) today announced the appointment of William W. Hurd, MD to the post of Chief Medical Officer.</p>
FAQs

FAQs

Have questions about IVF and infertility? We have answers.
Find A Clinic

Find A Clinic

National statistics from SART member clinics that reported their data through SART.